Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 5:17:751-762.
doi: 10.2147/IJGM.S453247. eCollection 2024.

A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome

Adrian Vasile Bota  1   2 , Iulia Bogdan  1   2   3 , David Vladut Razvan  1   2 , Adrian Cosmin Ilie  4 , Raluca Tudor  5 , Mirela Florica Indries  6 , Andrei Nicolae Csep  6 , Iosif Marincu  1
Affiliations

A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome

Adrian Vasile Bota et al. Int J Gen Med. .

Abstract

Background: This study explores the longitudinal psychosocial impact of Long-COVID syndrome, also known as Post-COVID-19 syndrome, characterized by enduring symptoms after coronavirus disease (COVID-19) infection, over the years 2020, 2021, and 2022. It aimed to examine the variations in depression, anxiety, and quality of life among Post-COVID-19 patients during these years, hypothesizing significant inter-year differences reflecting the pandemic's evolving influence.

Methods: Conducted at Victor Babes Hospital for Infectious Diseases and Pulmonology, Romania, this cross-sectional research involved 324 patients diagnosed with mild to moderate COVID-19, assessed six months post-hospitalization. Standardized instruments, namely Short Form (SF-36) for quality of life, Generalised Anxiety Disorder Assessment (GAD-7) for anxiety, and Patient Health Questionnaire (PHQ-9) for depression, were utilized.

Results: The study observed a consistent average patient age of around 55 years across the years. A notable increase in COVID-19 vaccination rates was recorded, rising from 20.9% in 2020 to over 70% in 2022 (p<0.001). Trends in key post-COVID symptoms like fatigue and cognitive issues varied over the years. Importantly, there was a consistent decrease in feelings of sadness or depression, with scores declining from 7.3 in 2020 to 4.8 in 2022 (p<0.001). The SF-36 survey indicated a steady improvement in overall health, reaching 55.8±7.1 in 2022 (p=0.035). Both GAD-7 and PHQ-9 scores showed significant reductions in anxiety and depression over the years, with p-values of 0.030 and 0.031, respectively. Factors such as smoking status, substance use, and the initial severity of COVID-19 infection were significantly associated with depression levels.

Conclusion: The findings suggest that despite persistent physical symptoms, Long-COVID patients experienced enhancements in mental well-being and quality of life over the studied period. The increasing vaccination rates might have contributed to this improvement. Addressing modifiable risk factors like smoking and substance use could further optimize post-COVID care and mental health outcomes.

Keywords: COVID-19; SARS-CoV-2; long-COVID; post, acute COVID; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Analysis of the SF-36 questionnaire results during the COVID-19 pandemic.
Figure 2
Figure 2
Analysis of the GAD-7 and PHQ-9 questionnaire results during the COVID-19 pandemic.
Figure 3
Figure 3
Regression analysis results.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lovato A, Rossettini G, de Filippis C. Sore throat in COVID-19: comment on ”Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis”. J Med Virol. 2020;92(7):714–715. doi:10.1002/jmv.25815 - DOI - PMC - PubMed
    1. Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020;179:85–100. PMID: 32971147; PMCID: PMC7505773. doi:10.1016/j.biochi.2020.09.018 - DOI - PMC - PubMed
    1. Dey A, Das R, Misra HS, Uppal S. Coronavirus disease 2019: scientific overview of the global pandemic. New Microbes New Infect. 2020;38:100800. PMID: 33133611; PMCID: PMC7591944. doi:10.1016/j.nmni.2020.100800 - DOI - PMC - PubMed
    1. Muntean D, Horhat FG, Bădițoiu L, et al. Multidrug-resistant gram-negative bacilli: a retrospective study of trends in a tertiary healthcare unit. Medicina. 2018;54(6). doi:10.3390/medicina54060092 - DOI - PMC - PubMed
    1. Toma AO, Prodan M, Reddyreddy AR, et al. The epidemiology of malignant melanoma during the first two years of the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health. 2022;20(1):305. doi:10.3390/ijerph20010305 - DOI - PMC - PubMed